ADAR1 prevents liver injury from inflammation and suppresses interferon production in hepatocytes

American Journal of Pathology

Volumn 185, Issue 12, 2015, Pages 3224-3237

  Wang, Guoliang ^a,b   Wang, Hui ^c   Singh, Sucha ^a   Zhou, Pei ^a   Yang, Shengyong ^a   Wang, Yujuan ^a   Zhu, Zhaowei ^a   Zhang, Jinxiang ^b   Chen, Alex ^a,d   Billiar, Timothy ^a   Monga, Satdarshan P ^a   Wang, Qingde ^a,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE ACTING ON RNA 1; HYDROLASE; INTERFERON; UNCLASSIFIED DRUG; ADAR1 PROTEIN, MOUSE; ADENOSINE DEAMINASE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; CYTOKINE; LIPID; PLASMA PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; FIBROSIS; GENE EXPRESSION; GROWTH RETARDATION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERFERON PRODUCTION; LIVER CELL; LIVER CELL CULTURE; LIVER FUNCTION; LIVER INJURY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; ANIMAL; BIOSYNTHESIS; BLOOD; CELL CULTURE; CELL DIFFERENTIATION; DEFICIENCY; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; HEPATITIS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

ADENOSINE DEAMINASE; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; BLOOD PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; HEPATITIS; HEPATOCYTES; INTERFERONS; LIPIDS; MICE, KNOCKOUT;

EID: 84947751144     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2015.08.002     Document Type: Article

References (74)

1. M. Zare-Bidaki, K. Tsukiyama-Kohara, and M. Kazemi Arababadi Toll-like receptor 4 and hepatitis B infection: molecular mechanisms and pathogenesis Viral Immunol 27 2014 321 326
2. C. Trepo, H.L. Chan, and A. Lok Hepatitis B virus infection Lancet 384 2014 2053 2063
3. S. Retamozo, C. Diaz-Lagares, X. Bosch, A. Bove, P. Brito-Zeron, M.E. Gomez, J. Yague, X. Forns, M.C. Cid, and M. Ramos-Casals Life-threatening cryoglobulinemic patients with hepatitis C: clinical description and outcome of 279 patients Medicine (Baltimore) 92 2013 245 256
4. M.G. Neuman, S.W. French, C.A. Casey, K.K. Kharbanda, R.M. Nanau, K. Rasineni, B.L. McVicker, V. Kong, and T.M. Donohue Jr. Changes in the pathogenesis of alcohol-induced liver disease: preclinical studies Exp Mol Pathol 95 2013 376 384
5. J. Yan, X. Wang, and S. Chen Systematic review of severe acute liver injury caused by terbinafine Int J Clin Pharm 36 2014 679 683
6. K. Izuishi, A. Tsung, M.A. Hossain, M. Fujiwara, H. Wakabayashi, T. Masaki, T.R. Billiar, and H. Maeta Ischemic preconditioning of the murine liver protects through the Akt kinase pathway Hepatology 44 2006 573 580
7. T. Chen, R. Zamora, B. Zuckerbraun, and T.R. Billiar Role of nitric oxide in liver injury Curr Mol Med 3 2003 519 526
8. C.R. Grant, R. Liberal, Y. Ma, S.C. Robson, G. Mieli-Vergani, D. Vergani, and M.S. Longhi Reply to phenotypic alterations of regulatory T cells in autoimmune hepatitis: causal or associated with treatment and remission? Hepatology 61 2015 737 738
9. V. Gordon, E. McFarlane, A. Dube, and D. Gleeson PTU-136 does a normal Igg indicate histological remission in autoimmune hepatitis (AIH)? Gut 63 Suppl 1 2014 A98
10. C.C. Duwaerts, and J.J. Maher Mechanisms of liver injury in non-alcoholic steatohepatitis Curr Hepatol Rep 13 2014 119 129
11. A. Berlanga, E. Guiu-Jurado, J.A. Porras, and T. Auguet Molecular pathways in non-alcoholic fatty liver disease Clin Exp Gastroenterol 7 2014 221 239
12. A. Kuhn, and A. Landmann The classification and diagnosis of cutaneous lupus erythematosus J Autoimmun 48-49 2014 14 19
13. K. Malm, S. Bergman, M. Andersson, and A. Bremander Predictors of severe self-reported disability in RA in a long-term follow-up study Disabil Rehabil 37 2015 686 691
14. A. Tsung, S. Tohme, and T.R. Billiar High mobility group box-1 in sterile inflammation J Intern Med 276 2014 425 443
15. M.T. Lotze, H.J. Zeh, A. Rubartelli, L.J. Sparvero, A.A. Amoscato, N.R. Washburn, M.E. Devera, X. Liang, M. Tor, and T. Billiar The Grateful Dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity Immunol Rev 220 2007 60 81
16. R. Gill, A. Tsung, and T. Billiar Linking oxidative stress to inflammation: toll-like receptors Free Radic Biol Med 48 2010 1121 1132
17. D. Tang, R. Kang, C.B. Coyne, H.J. Zeh, and M.T. Lotze PAMPs and DAMPs: signal 0s that spur autophagy and immunity Immunol Rev 249 2012 158 175
18. N. Nakamoto, and T. Kanai Role of toll-like receptors in immune activation and tolerance in the liver Front Immunol 5 2014 221
19. R. Medzhitov Toll-like receptors and innate immunity Nat Rev Immunol 1 2001 135 145
20. K. Takeda, and S. Akira Toll-like receptors in innate immunity Int Immunol 17 2005 1 14
21. J. Petrasek, A. Dolganiuc, T. Csak, B. Nath, I. Hritz, K. Kodys, D. Catalano, E. Kurt-Jones, P. Mandrekar, and G. Szabo Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells Hepatology 53 2011 649 660
22. Y. Zhai, B. Qiao, F. Gao, X. Shen, A. Vardanian, R.W. Busuttil, and J.W. Kupiec-Weglinski Type I, but not type II, interferon is critical in liver injury induced after ischemia and reperfusion Hepatology 47 2008 199 206
23. S. Ueki, R. Dhupar, J. Cardinal, A. Tsung, J. Yoshida, K.S. Ozaki, J.R. Klune, N. Murase, and D.A. Geller Critical role of interferon regulatory factor-1 in murine liver transplant ischemia reperfusion injury Hepatology 51 2010 1692 1701
24. A. Castellaneta, O. Yoshida, S. Kimura, S. Yokota, D.A. Geller, N. Murase, and A.W. Thomson Plasmacytoid dendritic cell-derived IFN-alpha promotes murine liver ischemia/reperfusion injury by induction of hepatocyte IRF-1 Hepatology 60 2014 267 277
25. J.R. Klune, R. Dhupar, S. Kimura, S. Ueki, J. Cardinal, A. Nakao, G. Nace, J. Evankovich, N. Murase, A. Tsung, and D.A. Geller Interferon regulatory factor-2 is protective against hepatic ischemia-reperfusion injury Am J Physiol Gastrointest Liver Physiol 303 2012 G666 G673
26. P. Loi, Q. Yuan, D. Torres, S. Delbauve, M.A. Laute, M.C. Lalmand, M. Petein, S. Goriely, M. Goldman, and V. Flamand Interferon regulatory factor 3 deficiency leads to interleukin-17-mediated liver ischemia-reperfusion injury Hepatology 57 2013 351 361
27. J.C. Hartner, C. Schmittwolf, A. Kispert, A.M. Muller, M. Higuchi, and P.H. Seeburg Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1 J Biol Chem 279 2004 4894 4902
28. Q. Wang, M. Miyakoda, W. Yang, J. Khillan, D.L. Stachura, M.J. Weiss, and K. Nishikura Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene J Biol Chem 279 2004 4952 4961
29. Q. Wang RNA editing catalyzed by ADAR1 and its function in mammalian cells Biochemistry (Mosc) 76 2011 900 911
30. W. Slotkin, and K. Nishikura Adenosine-to-inosine RNA editing and human disease Genome Med 5 2013 105
31. B.E. Wulff, and K. Nishikura Substitutional A-to-I RNA editing Wiley Interdiscip Rev RNA 1 2010 90 101
32. J. Laurencikiene, A.M. Kallman, N. Fong, D.L. Bentley, and M. Ohman RNA editing and alternative splicing: the importance of co-transcriptional coordination EMBO Rep 7 2006 303 307
33. A.G. Polson, B.L. Bass, and J.L. Casey RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase Nature 380 1996 454 456
34. C.M. Burns, H. Chu, S.M. Rueter, L.K. Hutchinson, H. Canton, E. Sanders-Bush, and R.B. Emeson Regulation of serotonin-2C receptor G-protein coupling by RNA editing Nature 387 1997 303 308
35. M. Higuchi, S. Maas, F.N. Single, J. Hartner, A. Rozov, N. Burnashev, D. Feldmeyer, R. Sprengel, and P.H. Seeburg Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2 Nature 406 2000 78 81
36. W. Yang, T.P. Chendrimada, Q. Wang, M. Higuchi, P.H. Seeburg, R. Shiekhattar, and K. Nishikura Modulation of microRNA processing and expression through RNA editing by ADAR deaminases Nat Struct Mol Biol 13 2006 13 21
37. A.K. Das, and G.G. Carmichael ADAR editing wobbles the microRNA world ACS Chem Biol 2 2007 217 220
38. Y. Kawahara, B. Zinshteyn, P. Sethupathy, H. Iizasa, A.G. Hatzigeorgiou, and K. Nishikura Redirection of silencing targets by adenosine-to-inosine editing of miRNAs Science 315 2007 1137 1140
39. B.S. Heale, L.P. Keegan, L. McGurk, G. Michlewski, J. Brindle, C.M. Stanton, J.F. Caceres, and M.A. O'Connell Editing independent effects of ADARs on the miRNA/siRNA pathways EMBO J 28 2009 3145 3156
40. H. Ota, M. Sakurai, R. Gupta, L. Valente, B.E. Wulff, K. Ariyoshi, H. Iizasa, R.V. Davuluri, and K. Nishikura ADAR1 forms a complex with Dicer to promote microRNA processing and RNA-induced gene silencing Cell 153 2013 575 589
41. W. Yang, Q. Wang, K.L. Howell, J.T. Lee, D.S. Cho, J.M. Murray, and K. Nishikura ADAR1 RNA deaminase limits short interfering RNA efficacy in mammalian cells J Biol Chem 280 2005 3946 3953
42. J.C. Hartner, C.R. Walkley, J. Lu, and S.H. Orkin ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling Nat Immunol 10 2009 109 115
43. W. Qiu, X. Wang, M. Buchanan, K. He, R. Sharma, L. Zhang, Q. Wang, and J. Yu ADAR1 is essential for intestinal homeostasis and stem cell maintenance Cell Death Dis 4 2013 e599
44. R. Dhupar, J.R. Klune, J. Evankovich, J. Cardinal, M. Zhang, M. Ross, N. Murase, D.A. Geller, T.R. Billiar, and A. Tsung Interferon regulatory factor 1 mediates acetylation and release of high mobility group box 1 from hepatocytes during murine liver ischemia-reperfusion injury Shock 35 2011 293 301
45. S. Hayashi, and A.P. McMahon Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse Dev Biol 244 2002 305 318
46. S. Yang, P. Deng, Z. Zhu, J. Zhu, G. Wang, L. Zhang, A.F. Chen, T. Wang, S.N. Sarkar, T.R. Billiar, and Q. Wang Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs J Immunol 193 2014 3436 3445
47. P.O. Seglen Preparation of isolated rat liver cells Methods Cell Biol 13 1976 29 83
48. R.D. Curran, T.R. Billiar, D.J. Stuehr, K. Hofmann, and R.L. Simmons Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells J Exp Med 170 1989 1769 1774
49. M.J. Scott, S. Liu, G.L. Su, Y. Vodovotz, and T.R. Billiar Hepatocytes enhance effects of lipopolysaccharide on liver nonparenchymal cells through close cell interactions Shock 23 2005 453 458
50. M.J. Scott, C. Chen, Q. Sun, and T.R. Billiar Hepatocytes express functional NOD1 and NOD2 receptors: a role for NOD1 in hepatocyte CC and CXC chemokine production J Hepatol 53 2010 693 701
51. R. Zamora, Y. Vodovotz, K.S. Aulak, P.K. Kim, J.M. Kane III, L. Alarcon, D.J. Stuehr, and T.R. Billiar A DNA microarray study of nitric oxide-induced genes in mouse hepatocytes: implications for hepatic heme oxygenase-1 expression in ischemia/reperfusion Nitric Oxide 7 2002 165 186
52. A. Suzuki, A. Iwama, H. Miyashita, H. Nakauchi, and H. Taniguchi Role for growth factors and extracellular matrix in controlling differentiation of prospectively isolated hepatic stem cells Development 130 2003 2513 2524
53. C. Postic, and M.A. Magnuson DNA excision in liver by an albumin-Cre transgene occurs progressively with age Genesis 26 2000 149 150
54. M.D. Thompson, E.D. Wickline, W.B. Bowen, A. Lu, S. Singh, A. Misse, and S.P. Monga Spontaneous repopulation of beta-catenin null livers with beta-catenin-positive hepatocytes after chronic murine liver injury Hepatology 54 2011 1333 1343
55. R.A. Steinman, Q. Yang, M. Gasparetto, L.J. Robinson, X. Liu, D.E. Lenzner, J. Hou, C. Smith, and Q. Wang Deletion of the RNA-editing enzyme ADAR1 causes regression of established chronic myelogenous leukemia in mice Int J Cancer 132 2013 1741 1750
56. H. Huang, G.W. Nace, K.A. McDonald, S. Tai, J.R. Klune, B.R. Rosborough, Q. Ding, P. Loughran, X. Zhu, D. Beer-Stolz, E.B. Chang, T. Billiar, and A. Tsung Hepatocyte-specific high-mobility group box 1 deletion worsens the injury in liver ischemia/reperfusion: a role for intracellular high-mobility group box 1 in cellular protection Hepatology 59 2014 1984 1997
57. H. Huang, J. Evankovich, W. Yan, G. Nace, L. Zhang, M. Ross, X. Liao, T. Billiar, J. Xu, C.T. Esmon, and A. Tsung Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice Hepatology 54 2011 999 1008
58. R. XuFeng, M.J. Boyer, H. Shen, Y. Li, H. Yu, Y. Gao, Q. Yang, Q. Wang, and T. Cheng ADAR1 is required for hematopoietic progenitor cell survival via RNA editing Proc Natl Acad Sci U S A 106 2009 17763 17768
59. R. Sharma, Y. Wang, P. Zhou, R.A. Steinman, and Q. Wang An essential role of RNA editing enzyme ADAR1 in mouse skin J Dermatol Sci 64 2011 70 72
60. Q. Wang, J. Khillan, P. Gadue, and K. Nishikura Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis Science 290 2000 1765 1768
61. A. Mallela, and K. Nishikura A-to-I editing of protein coding and noncoding RNAs Crit Rev Biochem Mol Biol 47 2012 493 501
62. Y. Nie, L. Ding, P.N. Kao, R. Braun, and J.H. Yang ADAR1 interacts with NF90 through double-stranded RNA and regulates NF90-mediated gene expression independently of RNA editing Mol Cell Biol 25 2005 6956 6963
63. C.X. George, and C.E. Samuel Host response to polyomavirus infection is modulated by RNA adenosine deaminase ADAR1 but not by ADAR2 J Virol 85 2011 8338 8347
64. C.E. Samuel Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral Virology 411 2011 180 193
65. Z. Li, K.M. Okonski, and C.E. Samuel Adenosine deaminase acting on RNA 1 (ADAR1) suppresses the induction of interferon by measles virus J Virol 86 2012 3787 3794
66. S. Akira, S. Uematsu, and O. Takeuchi Pathogen recognition and innate immunity Cell 124 2006 783 801
67. A. Pichlmair, and C.R.E. Sousa Innate recognition of viruses Immunity 27 2007 370 383
68. O. Takeuchi, and S. Akira MDA5/RIG-I and virus recognition Curr Opin Immunol 20 2008 17 22
69. H. Oshiumi, K. Funami, H.H. Aly, M. Matsumoto, and T. Seya Multi-step regulation of interferon induction by hepatitis C virus Arch Immunol Ther Exp (Warsz) 61 2013 127 138
70. P. Fickert, U. Stoger, A. Fuchsbichler, T. Moustafa, H.U. Marschall, A.H. Weiglein, O. Tsybrovskyy, H. Jaeschke, K. Zatloukal, H. Denk, and M. Trauner A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis Am J Pathol 171 2007 525 536
71. S. Sekine, R. Ogawa, R. Ito, N. Hiraoka, M.T. McManus, Y. Kanai, and M. Hebrok Disruption of Dicer1 induces dysregulated fetal gene expression and promotes hepatocarcinogenesis Gastroenterology 136 2009 2304 2315.e1-e4
72. S.H. Hsu, B. Wang, J. Kota, J. Yu, S. Costinean, H. Kutay, L. Yu, S. Bai, K. La Perle, R.R. Chivukula, H. Mao, M. Wei, K.R. Clark, J.R. Mendell, M.A. Caligiuri, S.T. Jacob, J.T. Mendell, and K. Ghoshal Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver J Clin Invest 122 2012 2871 2883
73. B. Gao, W.I. Jeong, and Z. Tian Liver: an organ with predominant innate immunity Hepatology 47 2008 729 736
74. T.H. Chan, C.H. Lin, L. Qi, J. Fei, Y. Li, K.J. Yong, M. Liu, Y. Song, R.K. Chow, V.H. Ng, Y.F. Yuan, D.G. Tenen, X.Y. Guan, and L. Chen A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma Gut 63 2014 832 843